Modular Medical R&D Spending Growth & History (MODD)
Modular Medical's r&d spending was $20.0M for fiscal 2026.
View full Modular Medical company overviewModular Medical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $20.0M | $5.3M | +35.90% |
| 2025 | 2025-03-31 | $14.7M | $1.8M | +14.11% |
| 2024 | 2024-03-31 | $12.9M | $3.8M | +42.13% |
| 2023 | 2023-03-31 | $9.1M | $1.3M | +17.24% |
| 2022 | 2022-03-31 | $7.7M | $3.6M | +89.29% |
| 2021 | 2021-03-31 | $4.1M | $1.0M | +34.58% |
| 2020 | 2020-03-31 | $3.0M | $1.2M | +61.19% |
| 2019 | 2019-03-31 | $1.9M | $1.5M | +465.88% |
| 2018 | 2018-03-31 | $332,642 | $332,642 | — |
| 2017 · Mar 31 | 2017-03-31 | $0 | — | — |
Modular Medical quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $4.4M | −$763,000 | −14.86% |
| Q4 2026 | 2026-03-31 | $3.8M | −$96,000 | −2.44% |
| Q3 2026 | 2025-12-31 | $5.4M | $1.6M | +40.28% |
| Q2 2026 | 2025-09-30 | $5.6M | $1.9M | +51.08% |
| Q1 2026 | 2025-06-30 | $5.1M | $1.9M | +60.19% |
| Q4 2025 | 2025-03-31 | $3.9M | $822,000 | +26.39% |
| Q3 2025 | 2024-12-31 | $3.9M | $15,000 | +0.39% |
| Q2 2025 | 2024-09-30 | $3.7M | $543,000 | +17.19% |
| Q1 2025 | 2024-06-30 | $3.2M | $437,000 | +15.79% |
| Q4 2024 | 2024-03-31 | $3.1M | $857,000 | +37.95% |
| Q3 2024 | 2023-12-31 | $3.8M | $1.6M | +74.69% |
| Q2 2024 | 2023-09-30 | $3.2M | $774,000 | +32.45% |
| Q1 2024 | 2023-06-30 | $2.8M | $546,000 | +24.57% |
| Q4 2023 | 2023-03-31 | $2.3M | $271,670 | +13.68% |
| Q3 2023 | 2022-12-31 | $2.2M | $347,601 | +18.80% |
| Q2 2023 | 2022-09-30 | $2.4M | $279,620 | +13.28% |
| Q1 2023 | 2022-06-30 | $2.2M | $433,869 | +24.26% |
| Q4 2022 | 2022-03-31 | $2.0M | $1.1M | +112.86% |
| Q3 2022 | 2021-12-31 | $1.8M | $762,730 | +70.19% |
| Q2 2022 | 2021-09-30 | $2.1M | $1.0M | +92.68% |
| Q1 2022 | 2021-06-30 | $1.8M | $817,316 | +84.19% |
| Q4 2021 | 2021-03-31 | $933,154 | — | — |
| Q3 2021 | 2020-12-31 | $1.1M | — | — |
| Q2 2021 | 2020-09-30 | $1.1M | $459,424 | +72.55% |
| Q1 2021 | 2020-06-30 | $970,815 | $267,032 | +37.94% |
| Q3 2020 · Dec 31 | 2019-12-31 | $608,019 | $103,232 | +20.45% |
| Q3 2020 · Dec 30 | 2019-12-30 | $608,019 | $103,232 | +20.45% |
| Q2 2020 | 2019-09-30 | $633,241 | $265,691 | +72.29% |
| Q1 2020 | 2019-06-30 | $703,783 | $567,994 | +418.29% |
| Q4 2019 | 2019-03-31 | $874,219 | $796,030 | +1018.08% |
| Q3 2019 | 2018-12-31 | $504,787 | $333,742 | +195.12% |
| Q2 2019 | 2018-09-30 | $367,550 | $284,142 | +340.67% |
| Q1 2019 | 2018-06-30 | $135,789 | $135,789 | — |
| Q4 2018 | 2018-03-31 | $78,189 | — | — |
| Q2 2018 | 2017-12-31 | $171,045 | $171,045 | — |
| Q1 2018 | 2017-09-30 | $83,408 | — | — |
| Q4 2017 · Jun 30 | 2017-06-30 | $0 | — | — |
| Q2 2017 | 2016-12-31 | $0 | — | — |
Modular Medical r&d spending trends
Over the last five fiscal years, Modular Medical's r&d spending increased from $4.1M to $20.0M, a change of $15.9M. The latest reported quarter, Q1 2027, shows $4.4M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Modular Medical source filings ↗